Core Insights - In the first half of 2025, the company achieved operating revenue of 41.679 billion yuan and a net profit attributable to shareholders of 29.0662 million yuan, marking a turnaround from losses in the previous year [1] - The company operates in three main sectors: crop science, trade, and specialty oils, with a strong emphasis on research and development [1][2] - The company ranks 218th on the 2025 Fortune China 500 list, indicating its significant market presence [1] Crop Science Sector - The company has established a comprehensive crop science enterprise group through mergers and acquisitions, with subsidiaries including Microlife Biotechnology and Kairi Biotechnology [2] - The crop science segment has over 50 products, including the leading biological fungicide Chuanlei Mersin, and exports to over 30 countries [2] - The company holds 71 invention patents and 39 utility model patents in the crop science field, with more than 20 invention patents currently under review [2] Trade Sector - The trade sector remains a pillar of the company's traditional business, focusing on commodities such as energy chemicals, metals, rubber, and sugar [2] - The company has established strategic partnerships with several Fortune 500 companies, providing comprehensive services to thousands of small and medium-sized enterprises in China [2] Specialty Oils Sector - The company’s subsidiary, Hongxin Foods, specializes in producing edible specialty oils, which are widely used in baking, dairy, and catering industries [3] - Hongxin Foods has obtained various quality management and safety certifications, ensuring product reliability [3] - The company plans to enhance its development in specialty oils through channel transformation and brand building [3] Future Strategy - The company aims to continue developing its commodity trade while advancing its strategic transformation in specialty oils and crop science [3] - The goal is to achieve organic synergy and rapid growth across the three sectors, moving towards becoming a large-scale integrated high-tech enterprise [3]

Company Performance - Far East Holdings (SZ 000626) reported a revenue of approximately 41.679 billion yuan for the first half of 2025, a decrease of 6.93% year-on-year [1] - The net profit attributable to shareholders was approximately 29.07 million yuan, with basic earnings per share of 0.0571 yuan [1] - In the same period of 2024, the company had a revenue of approximately 44.783 billion yuan and a net loss of approximately 40.36 million yuan, with basic earnings per share reflecting a loss of 0.0793 yuan [1] Market Context - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]

Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 41.679 billion yuan, a year-on-year decrease of 6.93% [1] - The net profit attributable to shareholders was 29.0662 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -1.25 billion yuan [1] - The basic earnings per share were 0.0571 yuan [1]

Core Viewpoint - The company, Yuanda Holdings, reported a significant increase in revenue and net profit for the first half of 2025, indicating a successful transition towards becoming a high-tech integrated enterprise in the agricultural sector [1] Group 1: Financial Performance - In the first half of 2025, Yuanda Holdings achieved an operating income of 41.679 billion yuan and a net profit attributable to shareholders of 29.0662 million yuan, representing a year-on-year growth of 172.02% [1] Group 2: Business Segments - Yuanda Holdings operates in three main sectors: crop science, trade, and specialty oils, with over 30 subsidiaries established in various countries and regions [2] - The company has a leading position in the microbial biopesticide market with its core product, Chuanlei Mei Su, and holds exclusive rights in the market for Zhongsheng Jun Su [2] Group 3: R&D and Innovation - The company emphasizes research and development, holding 75 invention patents and 73 utility model patents, and has established long-term collaborations with renowned universities and research institutions [2] - Yuanda Holdings aims to enhance its product pipeline through continuous innovation and integration of new technologies and products [4] Group 4: Agricultural Sector Transformation - The company has completed the initial phase of its industrial transformation in the crop science sector, focusing on green and sustainable agricultural practices [3] - Yuanda Holdings is expanding its business along the agricultural supply chain, providing comprehensive solutions for crop cultivation, including seeds, pesticides, and fertilizers [3] Group 5: Specialty Oils Market - The specialty oils sector is experiencing a shift towards high-end natural dairy products, with increasing demand for healthy and functional products [5] - Yuanda Holdings has developed a high-value product structure in the specialty oils market, achieving industry-leading standards in taste, nutrition, and quality [5] Group 6: Sales and Marketing Strategy - The company is enhancing its sales network and brand presence through various initiatives, including the establishment of an independent e-commerce department and a brand strategy upgrade [6] - Yuanda Holdings is focusing on high-end home baking scenarios to strengthen brand differentiation and market presence [6]

证券代码：000626 证券简称：远大控股 公告编号：2025-042 远大产业控股股份有限公司 关于公司全资子公司投资生产线建设项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、对外投资概述 1、情况概述 远大产业控股股份有限公司（以下简称：公司）全资子公司陕西麦可罗生物 科技有限公司（以下简称：麦可罗生物）出于产能扩张需要，拟在生产厂区内投 资 10,519.10 万元开展"生物农药生产线建设项目"。 公司名称：陕西麦可罗生物科技有限公司 公司类型：有限责任公司 法定代表人：伍晗辉 注册资本：5,000 万元 成立日期：2013 年 8 月 15 日 注册地址：陕西省渭南市蒲城县高新技术产业开发区 2、履行审批程序情况 2025 年 8 月 26 日，公司第十一届董事会召开 2025 年度第六次会议，审议 通过了《关于公司全资子公司投资生产线建设项目的议案》，该事项不构成关联 交易、不需提交公司股东大会审议，需要到有关部门办理备案手续。 二、投资主体介绍 经营范围：一般项目：生物农药技术研发；生物有机肥料研发；复合微生物 肥料研发；生物饲料研 ...

证券代码：000626 证券简称：远大控股 公告编号：2025-041 远大产业控股股份有限公司 关于为子公司提供担保的进展公告 | | 2025 | 年度已 | | 本次担保前 本次使用 | | --- | --- | --- | --- | --- | | | 审议担保预计 | | 2025 年度已 | 2025 年度 2025 年度可 担保余额 | | | | 额度 | 用担保额度 | 担保额度 用担保额度 | | 被担保方 陕西麦可罗生物科技有限公司 | | 0.7 | | 0.06 0.1 | | | | | | 本次担保后 0.54 | | | | | | 以前年度 0 | | | | | | 本次担保后 担保余额 0.16 | 三、被担保方基本情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别风险提示： 公司及控股子公司对外担保总额超过公司最近一期经审计净资产 100%；对资产负债率 超过 70%的单位担保金额超过公司最近一期经审计净资产 50%；对合并报表外单位担保金额 超过公司最近一期经审计净资产 30%，敬请投资者关注风险。 一、担 ...

远大产业控股股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 公司负责人：史迎春 主管会计工作的负责人：苏原 会计机构负责人：苏原 单位：人民币万元 非经营性资金占用 资金占用方名称 占用方与上市公 司的关联关系 上市公司核算 的会计科目 2025 年期初 占用资金余额 2025 年半年度占用累计 发生金额（不含利息） 2025 年半年度 占用资金的利息 2025 年半年度偿 还累计发生金额 2025 年半年度期 末占用资金余额 占用形成 原因 占用性质 现大股东及其附属企业 小计 前大股东及其附属企业 小计 总计 其他关联资金往来 资金往来方名称 占用方与上市公 司的关联关系 上市公司核算 的会计科目 2025 年期初 占用资金余额 2025 年半年度占用累计 发生金额（不含利息） 2025 年半年度 占用资金的利息 2025 年半年度偿 还累计发生金额 2025 年半年度期 末占用资金余额 占用形成 原因 占用性质 大股东及附属企业 小计 上市公司的子公司及其附属 企业 哈尔滨绿洲健身俱乐部有限公司 控股子公司 其他应收款 20.40 3.00 23.40 借款 非经营性占用 ...

远大产业控股股份有限公司 2025 年半年度财务报告 远大产业控股股份有限公司 2025 年半年度财务报告 2025 年 8 月 1 远大产业控股股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：远大产业控股股份有限公司 2025 年 06 月 30 日 3 远大产业控股股份有限公司 2025 年半年度财务报告 | 一年内到期的非流动负债 | 5,173,228.33 | 85,750,260.11 | | --- | --- | --- | | 其他流动负债 | 44,958,887.99 | 41,202,003.44 | | 流动负债合计 | 5,226,706,733.18 | 4,702,539,937.27 | | 非流动负债： | | | | 保险合同准备金 | | | | 长期借款 | 296,070,093.76 | 336,561,253.48 | | 应付债券 | | | | 其中：优先股 | | | | 永续债 | | | | 租赁负债 | 1, ...

证券代码：000626 证券简称：远大控股 公告编号：2025-040 远大产业控股股份有限公司 关于 2025 年半年度计提信用及资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、本次计提信用及资产减值准备的情况概述 为更加真实、准确地反映远大产业控股股份有限公司（以下简称：公司）2025 年 6 月 30 日的财务状况以及 2025 年上半年度经营成果，根据《企业会计准则》 及公司会计政策等相关规定，公司及下属子公司基于谨慎性原则，对各类资产进 行了清查、分析和评估，对部分可能发生信用及资产减值的资产计提了减值准备。 公司 2025 年上半年度（以下简称：本期）计提各项信用及资产减值准备具 体情况见下表： 单位：万元 除了单独评估信用风险的金融工具外，本公司基于共同风险特征将金融工具 1 | 项目 | 期初余额 | | | 本期变动金额 | | 期末余额 | | --- | --- | --- | --- | --- | --- | --- | | | | 计提 | 转回 | 转销/核销 | 其他 | | | 一、坏账准备 | 3,6 ...

远大产业控股股份有限公司(以下简称：公司)第十一届董事会 2025 年度第 六次会议通知于 2025 年 8 月 25 日以电子邮件方式发出，会议于 2025 年 8 月 26 日以通讯方式召开。本次会议应出席的董事人数为 13 名，实际出席的董事人数 为 13 名，公司监事列席本次会议。本次会议由董事长史迎春先生主持，会议的 召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的规定。 二、会议审议情况 1、审议通过了《关于 2025 年半年度报告全文及摘要的议案》。 详见公司 2025 年 8 月 27 日披露于《中国证券报》、《证券时报》和巨潮资讯 网（http://www.cninfo.com.cn）的《2025 年半年度报告全文》、《2025 年半年 度报告摘要》。 证券代码：000626 证券简称：远大控股 公告编号：2025-038 远大产业控股股份有限公司董事会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、会议召开情况 本议案获得的同意票数为 13 票、获得的反对票数为 0 票、获得的弃权票数 为 0 票，议案获得通过。 ...